Pfizer's best-selling product by far in 2023 was Comirnaty, its latest-generation Covid vaccine. It alone brought in about $11.2 billion. Its second most profitable product was Eliquis ...
By the 1960s, Pfizer were at their “most diversified point in [its] history” – in its own words, its interests “stretched from pills to perfume, and petrochemicals to pet products”.
Pfizer (PFE) is set to announce Q4 earnings, with analysts expecting a $0.46 profit per share and $17.26B revenue.
Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding covid-19-related product sales). While it historically sold many types of healthcare ...
Bourla outlined 2025 priorities, which include improving R&D productivity, achieving margin expansion, and maintaining commercial excellence. He highlighted expectations for nine Phase 3 readouts, 13 ...
Hosted on MSN1mon
Pfizer (PFE) Is Too Cheap To IgnoreOther relevant products are Prevnar 13 ... the stock might be too cheap to ignore. Pfizer does not rank on our latest list of the 31 Most Popular Stocks Among Hedge Funds. As per our database ...
STORY: Pfizer posted a better than expected fourth quarter profit on Tuesday (Feb 4).It was helped by cost cuts and a smaller-than-feared drop in sales of its COVID-19 vaccine.Pfizer's shares rose ...
Today, a brief rundown of news involving Pfizer, AbbVie and Royalty Pharma, as well as updates from Biogen and Alkeus Pharmaceuticals that you may have missed. Barinthus Biotherapeutics on Friday said ...
This World Cancer Day, Pfizer Canada ULC, together with Rethink Breast Cancer, Colorectal Cancer Canada, Lung Health ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results